• 出版社/出版日：Mordor Intelligence / 2021年7月31日
|Single User||￥467,500 (USD4,250)||▷ お問い合わせ|
|Team User||￥522,500 (USD4,750)||▷ お問い合わせ|
|Corporate License||￥825,000 (USD7,500)||▷ お問い合わせ|
・競争状況（Armstrong Medical Inc.、Ecomed、Merit Medical Systems、Salter Labs、Sarstedt AG & Co. KG、Smiths Medical、SunMed、Tapmedic LLC、Vyaire Medical, Inc.）
The Pressure Infusion Bags market studied is anticipated to grow with a CAGR of nearly 5.7%, during the forecast period.
Certain factors that are driving the market growth include rising prevalence of chronic diseases and surge in emergency transfusion cases and technological advancements and increasing R&D initiatives.
The pressure infuser has also become a necessary component of various medical procedures such as rapid infusion of blood, blood products, blood expanders, IV solutions, and invasive pressure monitoring procedures for instance. Intra‐arterial pressure monitoring and Swan‐Ganz catheterization monitoring both require the use of a pressurized plumbing system to retard the retrograde flow of blood and to keep the indwelling catheter patent. The infusor is used to pressurize a bag of heparinized saline to a pressure greater than the patient’s highest systolic blood pressure.
Key Market Trends
Outpatient Facilities show Lucrative Opportunity in the Global Pressure Infusion Bags Market
Outpatient Facility means a facility, located in or apart from a hospital, that provides, under the direction of a licensed physician, either diagnosis or treatment, or both, to ambulatory patients in need of medical, surgical, or mental care.
Throughout the past few decades, the treatment of various chronic diseases has been increasingly prioritized by the global health community or governments even in low- and middle-income countries. As a result, the demand for rapid fluid transfusion has risen significantly, in order to address the global disease burden, thus leading to a rise in utilization and adoption of Pressure Infusion Bags.
Over the past few years, with the move to value-based care, hospitals and healthcare systems are facing extreme competition from outpatient service sites, particularly those which offer physician office-based procedures, and ambulatory surgery. Gaining in popularity across the globe, outpatient facilities provide both operational and economic efficiencies, enabling ease of patient access, very competitive pricing, and increased opportunities for physician engagement. Hence, owing to all the aforementioned factors, the studied market is expected to increase in the future.
North America Dominates the Global Pressure Infusion Bags Market
North American dominates the Pressure Infusion Bags products market primarily due to high awareness regarding such health conditions. In addition, the rising prevalence of various chronic conditions is also fueling the market growth across the region.
According to the 2018 report published by the CDC, trauma and injuries are a leading cause of mortality in the United States. Trauma induced consumption and dilution of clotting factors, acidosis and hypothermia in a severely injured patient commonly causes trauma-induced coagulopathy. Early infusion of blood products and early control of bleeding decreases this trauma-induced coagulopathy. Hypothermia and dilutional coagulopathy are associated with infusion of large volumes of crystalloids. Hence, the predominant focus is on damage control resuscitation, which is a combination of permissive hypotension, hemorrhage control and hemostatic resuscitation. Massive transfusion protocols improve survival in severely injured patients. Early recognition that the patient will need massive blood transfusion can limit the use of crystalloids. Hence, due to the rising need for blood transfusion, the usage and adoption of pressure infusion bags is expected to grow significantly across the region.
The global Pressure Infusion Bags market is competitive and consists of a few major players. Companies like Armstrong Medical Inc., Ecomed, Merit Medical Systems, Salter Labs, Sarstedt AG & Co. KG, Smiths Medical, SunMed, Tapmedic LLC, Vyaire Medical, Inc., among others, hold the substantial market share in the market.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Chronic Diseases and Surge in Emergency Transfusion Cases
4.2.2 Technological Advancements and Increasing R&D Initiatives
4.3 Market Restraints
4.3.1 Lack of Skilled Professionals
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.2 By Material
5.3 By Application
5.3.1 Blood and Drug Infusion
5.3.2 Invasive Pressure Monitoring Procedures
5.4 By End-Users
5.4.1 Hospitals and Clinics
5.4.2 Outpatient Facilities
5.5.1 North America
18.104.22.168 United States
22.214.171.124 United Kingdom
126.96.36.199 Rest of Europe
188.8.131.52 South Korea
184.108.40.206 Rest of Asia-Pacific
5.5.4 Rest of the World
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Armstrong Medical Inc.
6.1.3 Merit Medical Systems
6.1.4 Salter Labs
6.1.5 Sarstedt AG & Co. KG
6.1.6 Smiths Medical
6.1.8 Tapmedic LLC
6.1.9 Vyaire Medical, Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS